Published Works:

1. Schenkel, A and Ordway, D. Developing a CURE program flexible for faculty/principal investigators (PIs) in a range of diverse research interests such as microbiology, immunology, and clinical pathology. (2019). CUREnet. Submitted

2. Raynaud C, Daher W, Roquet-Baneres F, Johansen MD, Stec J, Onajole OK, Ordway D, Kozikowski AP, and Kremer L. (2019). Synergistic interactions of indole-2-carboxamides and Beta-lactam antibioticsin Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy 63:e02245-18.

3. Prithwiraj D, Libin S, Boot C , Ordway D, McNeil D, Chatterjee D. (2019) Comparative structural study of terminal ends of lipoarabinomannan from lung tissues from mice, guinea pigs and urine from TB positive patient. ACS Infectious Diseases.
4. Xiyuan B, Verma D, Musheyev A, Garcia C, Kim K, Li L, Gadwa J, Ohanjanyan T, Ordway D, Chan ED. (2019) vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis. Immune Network. 018 Jun;18(3):e22.

5. Banaschewski B, Verma D, Pennings LJ, Zimmerman M, Ye Q, Gadawa J, Dartois V, Ordway D, van Ingen J, Ufer S, Stapleton K, Hofmann T. (2019) J Cyst Fibros. 2019 Sep;18(5):714-720. doi: 10.1016/j.jcf.2019.05.013. Epub 2019 May 25.

6. Verma D, Stapleton M, Gadwa J, Vongtongsalee K, Schenkel AR, Chan ED, and Ordway D. (2019). Mycobacterium avium infection in a In C3HeB/FeJ model. Frontiers Microbiology.

7. Pandya A, Kumar Prathipati P, Hegde P, Li W, Graham K, Mandal S, Drescher K, Destache C, Ordway D, Jackson M, and North E. (2019). Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model. Antimicrobial Agents and Chemotherapy. ntimicrob Agents Chemother. 2019 Feb 26;63(3). Front. Microbiol., 03 April 2019 |

8. Baldwin SL, Ordway D, Larson SE, Cassell G, Coler NR. (2018). The complexities and challenges of preventing and treating nontuberculous mycobacteria. PLOS Neglected Tropical Diseases. PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083. doi: 10.1371/journal.pntd.0007083. eCollection 2019 Feb.

9. Bai X, Aerts SL, Verma D, Ordway DJ, Chan ED. (2018). Epidemiologic Evidence of and Potential Mechanisms by Which Second-Hand Smoke Causes Predisposition to Latent and Active Tuberculosis. Immune Netw. Jun 26;18(3):e22. doi: 10.4110/in.2018.18.e22.

10. Shanley CA, Henao-Tamayo MI, Bipin C, Mugasimangalam R, Verma D, Ordway DJ, Streicher EM, Orme IM. (2018).Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission. Tuberculosis (Edinb). 2018 Mar;109:123-133. doi: 10.1016/

11. Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM. (2018). Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research. Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201807-1273PP.

12. Kozikowski A, Onajole O, Stec J, Dupont C, Viljoen A, Richard M, Chaira T, Lun S, Bishai W, Raj S, Ordway D, and Kremer L. (2017). Targeting mycolic acid transport by indole-2-carboxamides for the treatment of Mycobacterium abscessus infections J Med Chem 10.1021/acs.jmedchem. 7b00582.
13. Bernut, A, Herrmann J, Ordway D, Kremer L. (2017). Mini-Review: The diverse cellular and animal models to decipher the physiopathological traits of Mycobacterium abscessus infection. Front. Cell. Infect. Microbiol.

14. Ordway D, Verma D, Xiyuan B, and Chan E. (2016). Mini-Review: animal models of non-tuberculous mycobacterial infections. Mycobacterial Diseases. 6:216.

15. Bryant J, Grogono D, Rodriguez D, Everall I, Karen P, Brown P, Moreno, Verma D, Drijkoningen J, Gilligan P, Esther C, Noone P, Giddings O, Bell S, Thomson R, Claire E, Wainwright, Jones A, Bilton A, Laurenson I, Ruddy M, Smith G, Magee J, Bourke S, Bowler I, Chapman S, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M,Desai M, Drew R, Edenborough F, Evans J, Fenton P, Folb J, Humphrey H, Isalska B, Jönsson B, Jones A, GMacGregor G, Mayell S, Millar M, Modha D, Nash E, O’Brien C, Deirdre O’Brien, Ohri C, Pao C, Peckham D, Perrin F, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, van Ingen J, Walshaw, Danie M, Watson N, West N, Haworth C, SimonH, Ordway D, Parkhill J & R. Floto A. (2016) Emergence and spread of a human transmissible multidrug-resistant nontuberculous mycobacterium. Science. 354:751.

16. Henao-Tamayo M, Obregon-Henao A, Arnett K, Shanley C, Podell B, Orme I, Ordway D. (2016) Impact of BCG vaccination on CD4+Foxp3+ T cells during the acquired immune response to Mycobacterium tuberculosis infection. J Leukoc Biol. 99:605.

17. Conference report. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference Proceedings: National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014. Vaccine Prevention of Sustained Mycobacterium tuberculosis Infection Summary Group1. Aeras, Rockville, MD, USA. Behr M, Ellis R, Ernst J, Evans T, Flynn J, Hatherill M, Hoft D, Lalvani A, McShane H, Nardel E, Ordway D, Ramanathan R, Ruhwald M, Schlesinger L, Self S, Sizemore C, Walker B, White R, and Schrager L. (2015) Vaccine 33:3056

18. Obregón-Henao A, Arnett K, Henao-Tamayo M, Massoudi L, Creissen E, Andries K, Lenaerts AJ, Ordway DJ. (2015). Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models. Antimicrob Agents Chemother. 59:6904.

19. Bai X, Kinney W, Su W, Bai A, Ovrutsky A, Honda J, Netea M, Henao-Tamayo M, Ordway D, Dinarello C, Chan E. (2015). Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cells. BMC Microbiol. 15:39.

20. Bishwakarma R, Kinney W, Honda J, Mya J, Strand M, Gangavelli A, Bai X, Ordway D, Iseman M, Chan E. (2015). Epidemiologic link between tuberculosis and cigarette/biomass smoke exposure: Limitations despite the vast literature. Respirology. 20:556.

21. Bai X, Shang S, Henao-Tamayo MBasaraba R, Ovrutsky A, Matsuda J, Takeda K, Chan M, Dakhama A, Kinney W, Trostel J, Achcar R, Kim S, Dinarello C, Orme I, Ordway D, Chan E. (2015). Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis. PNAS. 112:5111.

22. Henao-Tamayo M, Obregón-Henao A, Shanley C, Creissen E, Orme I, Ordway D. (2015) Differential expression of BCG vaccine derived efficacy in C3Heb/FeJ and C3H HeOuJ mice exposed to clinical Mycobacterium tuberculosis. Clinical Vaccine Immunology Nov 12. pii: CVI.00466-14.

23. Schiebler M, Brown K, Hegyi K, Newton S, Renna M, Hepburn L, Schaffner C, Coulter S, Obregón-Henao A, Henao-Tamayo M, Basaraba R, Kampmann B, Henry K, Burgon J, Renshaw S, Fleming A, Kay R, Anderson K, Hawkins P, Ordway D, Rubinsztei D, Floto RA. (2014) Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion. EMBO Mol Medicine. pii: e201404137.

24. Aiyaz M, Bipin C, Pantulwar V, Mugasimangalam R, Shanley C, Ordway D, Orme IM. (2014) Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.Tuberculosis (Edinb). pii: S1472-9792(14)20491-4.

25. Chan E, Kinney W, Honda J, Bishwakarma R, Gangavelli A, Mya J, Xiyuan B, Ordway D. (2014) Tobacco exposure and susceptibility to tuberculosis: Is there a smoking gun? Tuberculosis. 94:544.

26. Orme I, Ordway D. (2014) The host response to non-tuberculous mycobacterial infections of current clinical importance. Infection and Immunity. 82:3516.

27. Henao-Tamayo M, Ordway D, Orme I. (2014) Memory T cell subsets in tuberculosis: what should we be targeting? Tuberculosis. 94:455.

28. Podell B, Ackart D, Obregon-Henao A, Eck S, Henao-Tamayo M, Richardson M, Orme I, Ordway D, Basaraba R. (2014) Increased severity of tuberculosis in guinea pigs with type 2 diabetes: A model of diabetes-tuberculosis comorbidity. The American Journal of Pathology, 184:1104.

29. Obregon A, Henao-Tamayo M, Ordway D. (2013). Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection. PLoS One, 8:e80669.

30. Bai X, Feldman NE, Chmura K, Ovrutsky AR, Su WL, Griffin L., Pyeon D, McGibney MT, Strand MJ, Numata M, Murakami S, Gaido L., Honda JR, Kinney WH, Oberley-Deegan RE, Voelker DR, Ordway DJ, Chan ED (2013). Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. PLoS One, 8:e61925.

31. Somashekar BS, Amin AG, Rithner CR, Ramamoorthy A, Shanley C, Obregon-Henao A, Basaraba R, Henao-Tamayo M, Kato-Maeda M, Orme I, Ordway D, Chatterjee D. (2012). Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis. J Proteome Res. 11:4873.

32. Obregón-Henao A, Shanley CS, Shang S, Caraway ML, Basaraba RJ, Duncan CL, Ordway DJ, Orme IM (2012). Cortisone-forced reactivation of weakly acid fast positive Mycobacterium tuberculosis in guinea pigs previously treated with chemotherapy. Mycobacterial Diseases.
Diane Ordway 12/30/2019

33. Kato-Maeda K, Shanley CA, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Cueto Barrozo J, Kawamura M, Hopewell PC, Ordway DJ, Orme IM. (2012). East-Asian (Beijing) sublineages of Mycobacterium tuberculosis differ in virulence and pathogenicity in the guinea pig. Clinical Vaccine Immunology. 19:1227.

34. Ordway DJ. (2012). Tuberculosis Research: One Mycobacterium tuberculosis bacilli for all. Editorial. Mycobacterial Diseases. 2:1

35. Walter ND, Strong M, Belknap R, Ordway DJ, Daley CL, Chan ED. (2012). Translating basic science insight into public health action for MDR- and XDR-TB. Respirology. 17:772.

36. Henao-Tamayo M, Obregón-Henao A, Shang S, Duncan CG, Ordway D, Orme IM. (2012). A mouse model of tuberculosis reinfection. Tuberculosis. 92:211.

37. Shang S, Shanley C, Caraway M, Orme E, Henao- Tamayo M, Hascall-Dove, Ackart D, Orme I, Ordway D, Basaraba R. (2012). Drug Treatment Combined with BCG Vaccination Reduces Disease Reactivation in Guinea Pigs Infected with Mycobacterium tuberculosis. Vaccine. 21: 1572.

38. Shang S, Gibbs S, Henao-Tamayo M, Shanley CA, McDonnell G, Duarte RS, Ordway DJ, Jackson M. (2011). Increased virulence of an epidemic strain of Mycobacterium massiliense in mice. PLoS One. 6: e24726.

39. Sweeney KA, Dao DN, Goldberg MF, Hsu T, Venkataswamy MM, Henao-Tamayo M, Ordway D, Sellers RS, Jain P, Chen B., Chen M., Kim J., Lukose R., Chan J., Orme I. M., Porcelli S. A., Jacobs W.R. (2011). A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nature Medicine. 17:1261.

40. Renna M, Schaffner C, Brown K, Shang S, Henao Tamayo M, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Newton S, Kampmann B, Haworth C, DeGroote MA, Ordway DJ, Rubinsztein DC, Floto RA. (2011). Azithromycin blocks autophagy and predisposes to mycobacterial infection. Journal Clinical Investigation. 121:3554.

41. Honda JR, Shang S, Shanley C A, Caraway ML, Henao-Tamayo M, Chan ED, Basaraba RJ, Orme I M, Ordway DJ, Flores, SC. (2011). Immune Responses of HIV-1 Tat Transgenic Mice to Mycobacterium Tuberculosis W-Beijing SA161. The Open AIDS Journal. 5:86.

42. Shang S, Harton M, Tamayo MH, Shanley C, Palanisamy GS, Caraway M, Chan ED, Basaraba R J, Orme IM, Ordway DJ (2011). Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. Tuberculosis. 91:378.

43. Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, Shanley CA, Basaraba RJ, Duncan CG, Orme IM. (2011). BCG-mediated protection against W. Beijing Strains of Mycobacterium Tuberculosis is diminished concomitant with the emergence of regulatory Tcells. Clinical Vaccine Immunology. 18:1527

44. Henao-Tamayo M, Irwin SM, Shang S, Ordway DJ, Orme IM. (2011). T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis. Tuberculosis. 91:308.

45. Shang S, Ordway DJ, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley CA, Orme IM, Case S, Minor M, Ackart D, Hascall-Dove L, Ovrutsky AR, Kandasamy P, Voelker DR, Lambert C, Freed BM, Iseman MD, Basaraba RJ, Chan ED. (2011). Cigarette smoke increases susceptibility to tuberculosis—evidence from in vivo and in vitro models. Journal of Infectious Disease. 203:1240.

46. Baia X, Chmura K, Ovrutsky AR, Russell PB, Scheinmane R, Oberley-Deegan RE, Liuf H, Shang S, Ordway DJ, Chan ED. (2011). M. tuberculosis increases IP-10 and MIG protein despite inhibition of IP-10 and MIG transcription. Tuberculosis. 91:26.

47. Shang S, Shanley CA, Caraway ML, Orme EA, Henao-Tamayo M, Hascall-Dove L, Ackart D, Lenaerts AJ, Basaraba RJ, Orme IM, Ordway DJ. (2011). Activities of TMC 207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs. Antimicrob Agents Chemother. 55:124-31.

48. Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, Kahn M, Phan T, Orme IM, Vedvick TS, Baldwin SL, Coler RN, Reed SG. (2010). A Defined Tuberculosis Vaccine Candidate to Boost BCG and Protect against Multidrug-Resistant Mycobacterium tuberculosis. Science Translational Medicine. 2:53ra74.

49. Chan ED, Bai X, Kartalija M, Orme IM, Ordway DJ. (2010). Host immune response to rapidly-growing mycobacteria, an emerging cause of chronic lung disease. American Journal of Respiratory Cell Molecular Biology. 43:387.

50. Henao-Tamayo MI, Ordway DJ, Irwin SM, Shanley CA, Orme IM. (2010). Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clinical Vaccine Immunology. 17:618.

51. Morris KR, Ryan DL, Bai X, McGibney M, Cook D, Ordway D, Chan ED. (2009). Suppression of IFNγ + mycobacterial lipoarabinomannan-induced nitric oxide by IL-4 is due to decreased IRF-1 expression and not increased arginase activity. Tuberculosis. 89:294.

52. Henao-Tamayo M, Palaniswamy GS, Smith EE, Shanley CA, Wang B, Orme IM, Basaraba RJ, DuTeau NM, Ordway D. (2009). Post-exposure vaccination against Mycobacterium tuberculosis. Tuberculosis. 89:142.

53. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M., Basaraba RJ, Hanneman WH, Orme IM and Slayden RA (2009). Trends in the Immune Response to Pulmonary Mycobacterium tuberculosis Infection and Identification of Molecular Markers of Disease Progression. American Journal of Respiratory Cell Molecular Biology. 40:398.

54. Ordway D, Henao-Tamayo M, Shanley C, Smith EE, Palanisamy G, Wang B, Basaraba RJ, Orme IM. (2008). The influence of BCG vaccination on the cellular immune response in immune guinea pigs infected with Mycobacterium tuberculosis. Clinical Vaccine Immunology. 25:1248.

55. Palanisamy GS, Smith EE, Shanley CA, Ordway DJ, Orme IM, Basaraba RJ. (2008). Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model. Tuberculosis. 88:295.

56. Ordway D, Henao-Tamayo M, Smith E, Shanley C, Harton M, Troudt J, Bai X, Basaraba RJ, Orme IM, Chan E D. (2008). Animal model of Mycobacterium abscessus lung infection. Journal Leukocyte Biology. 83:1502.

57. Henao-Tamayo M, Junqueira-Kipnis AP, Ordway D, Gonzales-Juarrero M, Stewart GR, Young D B, Wilkinson RJ, Basaraba RJ, Orme IM. (2007). A mutant of Mycobacterium tuberculosis lacking the 19-kilodalton lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties. Vaccine. 25:7153-9.

58. Ordway D., Higgins DM, Sanchez-Campillo J, Spencer J, Henao-Tamayo M, Harton M, Orme I, Gonzalez-Juarrero M. (2007). XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-γ by CD4 T cells and participates in granuloma stability. Journal Leukocyte Biology. 82:1221.

59. Ordway D, Palanisamy G, Henao-Tamayo M, Smith E, Shanley C. Orme IM, Basaraba RJ. (2007). Cellular immune responses during Mycobacterium tuberculosis infection in the guinea pig. Journal of Immunology. 179:2532.

60. Wang B, Henao-Tamayo M, Harton M, Ordway DJ, Shanley C, Basaraba RJ, Orme IM. (2007). A Toll-like Receptor-2 directed fusion protein vaccine against tuberculosis. Clinical Vaccine Immunology. 14:902.

61. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C, Basaraba RJ, Orme IM. (2007). The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. Journal of Immunology. 179:522.

62. Kristiansen MM, Leandro C, Ordway DJ, Martins M, Viveiros M, Pacheco T, Molnar J, Kristiansen JE, Amaral L. (2006). Thioridazine Reduces Resistance of Methicillin-Resistant Staphylococcus aureus by Inhibiting a Reserpine Sensitive Efflux Pump. In Vivo. 20:361.

63. Ordway, DJ, Harton M, Henao-Tamayo M, Orme IM, Gonzalez-Juarrero M. (2006). Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis. Journal of Immunology. 176:4931.

64. Park JS, Henao-Tamayo M, Gonzalez-Juarrero M, Orme IM, Ordway DJ. (2006). Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis in murine macrophages. Journal of Leukocyte Biology. 79:80.

65. Ordway DJ, Viveiros M, Ventura FA, Orme IM, Dockrell HM, Amaral L. (2005). Exogenous re-infection by multiple exposures to Mycobacterium tuberculosis contributes to subsequent development of active tuberculosis. American Journal of Immunology. 1:42.

66. Ordway DJ, Marta M, Costa LM, Freire MS, Arroz MJ, Dockrell HM, Ventura FA. (2005). Increased IL-4 production in response to virulent Mycobacterium tuberculosis in tuberculosis patients with advanced disease. Acta Medicia Portuguese. 18:27.

67. Ordway, DJ, Viveiros M, Ventura FA, Dockrell HM, Amaral L. (2005). Does multiple exposure to Mycobacterium tuberculosis lead to reduction of a Th1 immune response and concomitant presence of Th2 immune response which contributes to subsequent development of active tuberculosis? Research Advances in Infectious Diseases. 3:15.

68. Ordway D, Henao-Tamayo M, Orme IM, Gonzalez-Juarrero M. (2005). Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and express anti-apoptotic markers of the TRAF family. Journal of Immunology. 175:3873.

69. Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway DJ, Molnar AM, Molnar J, Amaral L. (2005). Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and the expression of proton gradient dependent multidrug efflux pump genes. Antimicrobial Agents and Chemotherapy. 49:3578.

70. Taylor JL, Ordway DJ, Trout J, Gonzales-Juarrero M, Basaraba RJ, Orme IM. (2005). Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA. Infection and Immunity. 73:5189.

71. Ordway DJ, Pinto L, Costa L, Martins M, Leandro C, Viveiros M, Amaral L, Arroz MJ, Ventura F A, Dockrell HM. (2005). Gamma delta T cell responses associated with the development of Tuberculosis in health care workers. FEMS Immunology & Medical Microbiology. 43:339.

72. Martins M. Ordway DJ, Kristiansen M, Viveiros M, Leandro C, Molnar J, Amaral L. (2005). Inhibition of the Carpobrotus edulis methanol extract on the growth of phagocytosed multi-drug resistant Mycobacterium tuberculosis and methicillin resistant Staphylococcus aureus. Fitoterapia. 76:96.

73. Martins M, Bleiss W, Marko A, Ordway D, Leandro C, Pacheco T, Molnar J, Kristiansen JE, Amaral L. (2004). Clinical Concentrations of Thioridazine Enhance the Killing of Intracellular Methicillin-resistant Staphylococcus Aureus: an in Vivo, ex Vivo, and Electron Microscopy Study. In Vivo. 18:787.

74. Ordway DJ, Costa L, Martins M, Silveira H, Amaral L, Arroz MJ, Ventura FA, Dockrell H. (2004). Increased IL-4 responses to virulent Mycobacterium tuberculosis in health care workers, who went on to present with primary TB. Journal of Infectious Disease. 190:1642.

75. Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T, Kristiansen JE, Amaral L. (2003). Phenothiazines alter resistance of methicillin-resistant strains ofStaphylococcus aureus (MRSA) to oxacillin in vitro. International Journal of Antimicrobial Agents. 22:250.

76. Ordway DJ, Silveira H, Costa L, Costa S, Martins M, Badura R, Arroz MJ, Dockrell HM, Young S, Ventura FAAN. (2002). Comparacao das respostas celulares imunes induzidas por proteinas filtradasda culturade Mycobacterium tuberculosis. Review Portuguese Pneumology. 8:232.

7. Ordway DJ, Hohmann J, Viveiros M, Viveiros A, Molnar J, Leandro C, Arroz MJ, Amelia Gracio M, Amaral L. (2003). Methanol extract of Carpobrotus edulis inhibits the multidrug resistance efflux pumps, enhances killing of Staphylococcus aureus phagocytosed and promotes immune modulation. Phytotherapy Research. 17:512.

78. Ordway D, Viveiros M, Leandro C, Amaral L. (2003). Chlorpromazine and Thioridazine have intracellular killing activity against phagocytosed multi-drug resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 47:917.

79. Ordway D, Viveiros M, Leandro C, Arroz MJ, Molnar J, Kristiansen JE, Amaral L. (2002). Chlorpromazine has intracellular killing activity against Staphylococcus aureus infections at clinical concentrations. Journal of Infection Chemotherapy. 8:227.

80. Viveiros M, Portugal I, Bettencourt R, Victor T, Leandro C, Ordway D, Amaral L. (2002). Isoniazied-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 46:2804.

81. Ordway D, Viveiros M, Leandro C, Arroz MJ, Amaral L. (2002). Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus. Internation Journal of Antimicrobial Agents. 20:34.

82. Ordway D, Ventura F. (2001). Interaccoes imunologicas e clinicas – Tuberculose e infeccao pelo VIH (II). Mundo Medica. 16: 102.

83. Ordway D, Ventura F. (2001). Interaccoes imunologicas e clinicas – Tuberculose e infeccao pelo VIH (I). Mundo Medicia. 15: 109.

84. Ordway D, Arroz J, Ferreira M, Dockrell H, Ventura F. (2001). Respostas das citocinas T 2 desencadeadas por Mycobacterium tuberculosis virulento em doentes com tuberculose pulmonar em estado avançado. Revista Portuguese Pneumology. 12:101.

85. David S, Ordway D, Arroz MJ, Costa J, Delgado R. (2001). Activity against Mycobacterium tuberculosis with concomitant induction of cellular immune responses by tetra-macrocycle with acetate pendant arms. Research Microbiology. 152:569.

86. Messias A, Araujo C, Lino S, Pacheco T, Mansinho K, Ordway D, Ventura FAAN. (2000). Condensacao pulmonar cavitada por Rhodococcus equi, mun individuo seropositivo para o VIH. Acta Medica Portuguesa. 13:32.

87. Moraes MF, Ordway D, Oliveira L, Costa I L, Badura R, Pinheiro MN, Pimenta da Graca JM, Ventura FA A N. (1999). Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu’s arteriti. Revista Portuguese Cardiology. 18:359.

8. Ordway D, Oliveira L, Moraes MF, Saldanha T, Pinheiro MN, Pimenta Graca JM, Carvalho L, Badura R, Abecasis P, Ventura FAAN. (1998). Respostas Imuno-Celulares A Antigénios Micobacteriano. Acta Medica Portugesa. 14:883.

89. Ordway DJ, Arroz M J, Fernandes A, Dockrell HM, Ventura FA. (1998). Respostas Th1 e Th2 desencadeas por Mycobacterium tuberculosis virulento em doentes com tuberculose. pulmona. Revista Portuguesa de Pneumology. 4:393.

90. Silveira H, Ordway D, Dockrell H, Jackson M, Ventura F. (1997). Cell-Mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clinical Experimental Immunology. 110:26.

91. Ordway DJ, Furney SK, Brennan PJ, Belisle JT, Orme IM. (1995). Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology. 85:502.

92. Ordway DJ, Sonnenberg MG, Donahaue SA, Belisle JT, Orme IM. (1995). Drug resistance strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infection and Immunity. 6:741.

93. Roberts AD, Ordway DJ, Orme IM. (1993). Listeria monocytogenes infection in B2 microglobutin-deficient mice. Infection and Immunity. 61:1113.

Book Chapters and Non-Refereed Publications:

1. Edward Chan and Ordway DJ, (2020). Current Protocols in Immunology. Unit 19.5, Animal
Models of Mycobacterial Infection. John Wiley & Sons, Inc. submitted.

2. Sven Hoffner, Michael M. Chan, Edward D. Chan, (2020) Diane Ordway, Drug Discovery Targeting Drug Resistant Non-Tuberculous Mycobacteria Nontuberculous Mycobacteria, 2st edition, Elsevier Press. Submitted.

3. Hoffman S, Ordway DJ (2019). Chapter 4, The Role of Drug Susceptibility Testing of Non-Tuberculous Mycobacteria, Nontuberculous Mycobacteria, 1st edition, Elsevier Press.

4. Orme IM, Ordway DJ (2016). Chapter 7, Mouse and guinea pig models of tuberculosis., Tuberculosis and the Tubercle Bacillus, 2nd edition, Microbiology Spectrum, American Society of Microbiology Press.

5. Brighenti S, Ordway DJ (2016). Chapter 3, Acquired immunity: Immunoregulation. Tuberculosis and the Tubercle Bacillus, 2nd edition, Microbiology Spectrum, American Society of Microbiology Press.

6. Ordway D J, Orme IM (2011). Methods in Microbiology, Volume 37. Chapter 12, Murine and Guinea Pig Models of Tuberculosis. 3rd edition of Immunology of Infection, John Wiley & Sons, Inc.

7. Ordway DJ, Orme IM (2011). Current Protocols in Immunology. Unit 19.5, Animal Models of Mycobacterial Infection. John Wiley & Sons, Inc.